ITT Other Income (Expense) increased by 58.3% to $1.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 90.0%, from $1.00M to $1.90M. Over 3 years (FY 2022 to FY 2025), Other Income (Expense) shows an upward trend with a 180.2% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.50M | -$500.00K | $200.00K | -$500.00K | -$2.30M | $2.80M | -$3.50M | -$2.50M | -$1.40M | $9.10M | -$4.40M | $200.00K | $200.00K | $5.60M | $1.00M | -$700.00K | $2.90M | $1.20M | $1.90M |
| QoQ Change | — | -114.3% | +140.0% | -350.0% | -360.0% | +221.7% | -225.0% | +28.6% | +44.0% | +750.0% | -148.4% | +104.5% | +0.0% | >999% | -82.1% | -170.0% | +514.3% | -58.6% | +58.3% |
| YoY Change | — | — | — | -114.3% | -360.0% | — | <-999% | -400.0% | +39.1% | +225.0% | -25.7% | +108.0% | +114.3% | -38.5% | +122.7% | -450.0% | >999% | -78.6% | +90.0% |